Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors

<p>Suppl table 3</p>

Saved in:

Bibliographic Details
Main Author:	Elena Llano (14963220) (author)
Other Authors:	Anne Laure Todeschini (14963223) (author), Natalia Felipe-Medina (14963226) (author), María D. Corte-Torres (14963229) (author), Yazmine B. Condezo (14963232) (author), Manuel Sanchez-Martin (14963235) (author), Sara López-Tamargo (14963238) (author), Aurora Astudillo (14963241) (author), Xose S. Puente (14935902) (author), Alberto M. Pendas (14963244) (author), Reiner A. Veitia (14963247) (author)
Published:	2025
Subjects:	Cancer Cancer Biology Molecular and Cellular Biology Carcinogenesis Animal models of carcinogenesis Genome Biology Comparative transcriptomics Gynecological Cancers Ovarian cancer
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
by: Elena Llano (14963220)
Published: (2025)

Table S5 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
by: Elena Llano (14963220)
Published: (2025)

table s1 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
by: Elena Llano (14963220)
Published: (2025)

table s4 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
by: Elena Llano (14963220)
Published: (2025)

Table 3_Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.docx
by: Sofia Maria Carlotta Arnaboldi (22671431)
Published: (2025)

Table 2_Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.docx
by: Sofia Maria Carlotta Arnaboldi (22671431)
Published: (2025)

Table 1_Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.docx
by: Sofia Maria Carlotta Arnaboldi (22671431)
Published: (2025)

Data Sheet 1_Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.docx
by: Sofia Maria Carlotta Arnaboldi (22671431)
Published: (2025)

Table 1_Gold nanoparticles in the diagnosis and treatment of ovarian and cervical cancers: a comprehensive understanding.xlsx
by: Senhui Zhang (22234723)
Published: (2025)

Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
by: Eleonora Khlebus (15307262)
Published: (2025)

Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
by: Eleonora Khlebus (15307262)
Published: (2025)

Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
by: Eleonora Khlebus (15307262)
Published: (2025)

Figure 1 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Figure 2 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Figure 3 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Figure 4 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Figure 5 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Supplementary Table S1 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Supplementary Table S2 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Supplementary Table S3 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Supplementary Table S4 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
by: Eleonora Y. Khlebus (20814571)
Published: (2025)

Supplemental Table S3 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
by: Yeh Wang (14964041)
Published: (2025)

Supplemental Table S4 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
by: Yeh Wang (14964041)
Published: (2025)

Supplementary Table S4 from Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level
by: Arnaud Da Cruz Paula (17316230)
Published: (2025)

Supplementary Figure 1 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Figure 2 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Figure 3 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Figure 4 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 1 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 2 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 3 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 4 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 5 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 6 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 7 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Supplementary Table 8 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
by: Victoria Cluzet (21904843)
Published: (2025)

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
by: Nicola S. Meagher (15048462)
Published: (2025)

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
by: Nicola S. Meagher (15048462)
Published: (2025)

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
by: Nicola S. Meagher (15048462)
Published: (2025)

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
by: Nicola S. Meagher (15048462)
Published: (2025)